NIH Grant Award on Use on Whole Genome Sequencing

HBHE Genetics group to play a key role in a major NIH grant awarded to the University of Michigan to explore the use of genome sequencing in medical care.
07/23/2013

Advances in whole genome sequencing are enabling researchers to uncover new targets for cancer treatment, but these advances raise potential ethical and psychosocial issues that will need to be addressed if the full potential of sequencing is to be realized. On July 23, our research team was funded to conduct research as part of the National Human Genome Research Institute's (NHGRI) Clinical Sequencing Exploratory Research (CSER) program. The University of Michigan was awarded a $7.97 million grant for the MI-ONCOSEQ project that will investigate the use of genome sequencing in tumors of patients with advanced sarcomas or other rare cancers. Our team will help evaluate the patient consent process, as well as the delivery and use of genome sequencing results.

For more information about the NHGRI 2013 Press Release as well as additional information about the other funded projects please visit the NHGRI website or click here for the direct link to the press release.